503 related articles for article (PubMed ID: 16083703)
21. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
[TBL] [Abstract][Full Text] [Related]
22. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
[TBL] [Abstract][Full Text] [Related]
23. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer.
Miyata Y; Sakai H; Hayashi T; Kanetake H
Prostate; 2003 Feb; 54(2):125-32. PubMed ID: 12497585
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
Serrano ML; Romero A; Cendales R; Sánchez-Gómez M; Bravo MM
Biomedica; 2006 Jun; 26(2):258-68. PubMed ID: 16925098
[TBL] [Abstract][Full Text] [Related]
25. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
[TBL] [Abstract][Full Text] [Related]
27. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
[TBL] [Abstract][Full Text] [Related]
28. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
Lacey JV; Potischman N; Madigan MP; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR; Fillmore CM; Sherman ME; Brinton LA
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):607-12. PubMed ID: 15066926
[TBL] [Abstract][Full Text] [Related]
30. [Study on the relations between serum insulin-like growth factor-1, insulin-like growth factor binding protein-3 and colorectal cancer: a meta-analysis].
Duan QH; Wang ZG; Zhu GB; Lu ZX; Shi LY; Nie SF
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Feb; 26(2):132-4. PubMed ID: 15921617
[TBL] [Abstract][Full Text] [Related]
31. Selenium, apoptosis, and colorectal adenomas.
Connelly-Frost A; Poole C; Satia JA; Kupper LL; Millikan RC; Sandler RS
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):486-93. PubMed ID: 16537706
[TBL] [Abstract][Full Text] [Related]
32. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
Harris TG; Strickler HD; Yu H; Pollak MN; Monrad ES; Travin MI; Xue X; Rohan TE; Kaplan RC
Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
[TBL] [Abstract][Full Text] [Related]
33. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
Han JY; Choi BG; Choi JY; Lee SY; Ju SY
Lung Cancer; 2006 Nov; 54(2):227-34. PubMed ID: 16935391
[TBL] [Abstract][Full Text] [Related]
34. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
Eng-Wong J; Hursting SD; Venzon D; Perkins SN; Zujewski JA
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1468-73. PubMed ID: 14693739
[TBL] [Abstract][Full Text] [Related]
35. Biopsy of colorectal polyps is not adequate for grading of neoplasia.
Gondal G; Grotmol T; Hofstad B; Bretthauer M; Eide TJ; Hoff G
Endoscopy; 2005 Dec; 37(12):1193-7. PubMed ID: 16329016
[TBL] [Abstract][Full Text] [Related]
36. Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
Oliver SE; Holly J; Peters TJ; Donovan J; Persad R; Gillatt D; Pearce A; Hamdy FC; Neal DE; Gunnell D
Urology; 2004 Aug; 64(2):317-22. PubMed ID: 15302487
[TBL] [Abstract][Full Text] [Related]
37. Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon.
Yoshida I; Suzuki A; Vallée M; Matano Y; Masunaga T; Zenda T; Shinozaki K; Okada T
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1225-31. PubMed ID: 16979948
[TBL] [Abstract][Full Text] [Related]
38. Interactions between insulin, body fat, and insulin-like growth factor axis proteins.
Ahmed RL; Thomas W; Schmitz KH
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):593-7. PubMed ID: 17372257
[TBL] [Abstract][Full Text] [Related]
39. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy.
Brenner H; Haug U; Arndt V; Stegmaier C; Altenhofen L; Hoffmeister M
Gastroenterology; 2010 Mar; 138(3):870-6. PubMed ID: 19909750
[TBL] [Abstract][Full Text] [Related]
40. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]